Skip to main content

Advocating for Patients

Advocacy Update: Funding for Asthma Programs and Food Allergy Research, Protections for Students, and Action on Sesame Allergy

Great Strides in July 2020 for People With Asthma and Allergies AAFA has made great strides this month in advocating for policies that protect people with asthma and allergies. The House Energy and Commerce Committee passed the School-Based Allergies and Asthma Management Program Act (H.R. 2468) and the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act (H.R. 2117) . These have been top priority issues for our organization and we're excited for this progress! UPDATE...

Coronavirus (COVID-19) Crisis: Some States Open Enrollment for Health Insurance

Update – July 20, 2020 We have updated this blog post to reflect which states have ended or extended their open enrollment periods. With the spread of the new coronavirus (COVID-19) , many uninsured people are concerned about medical costs if they get sick. Several states have opened up their health care exchanges for a special open enrollment period. Some states are also giving people who’ve lost their jobs the chance to enroll. If you need insurance, you can enroll in the following states:...

Asthma and Allergy Research With You as an Equal Partner

The Asthma and Allergy Foundation of America (AAFA) conducts and promotes patient-centered research to help you. This means your beliefs, preferences and needs are at the center of our research. Your input drives our advocacy work, guides our education programs and supports our community. Recently, we’ve studied the following topics: Symptoms of anaphylaxis in infants and toddlers Eczema burdens and people’s experiences with treatments Impact of COVID-19 on people with asthma and allergy Air...

Letter to the FDA: Require Food Manufacturers to Post Substitutions

On May 22, 2020, the Food and Drug Administration (FDA) relaxed labeling guidelines for food companies . This is a temporary measure because of food supply issues due to COVID-19 (the new coronavirus). The Asthma and Allergy Foundation of America (AAFA) met with the FDA to talk about how this will affect the food allergy community. After the meeting, we organized a joint letter with other food allergy advocacy organizations to send to the FDA. The letter addresses the FDA’s short-term food...

Congress Recognizes May as National Asthma and Allergy Awareness Month

The U.S. House of Representatives has declared their support for National Asthma and Allergy Awareness Month . Reps. Eliot Engel (D-NY), Fred Upton (R-MI), TJ Cox (D-CA) and Peter King (R-NY) submitted the resolution to the House Committee on Energy and Commerce on May 8, 2020. May is peak season for people with asthma and allergies. That’s why the Asthma and Allergy Foundation of America (AAFA) chose it as a time to raise awareness and educate people on how to manage these conditions. Read...

COVID-19 and Its Impact on People With Asthma and Allergies: A Global Health Crisis

The Asthma and Allergy Foundation of America (AAFA) has been fighting to save lives for nearly 70 years. With your support, we provide education, conduct patient-centered research and advocate for protections for our community. Our experience and strong community ties allowed us to take prompt action on the COVID-19 crisis . Thanks to your generous support, we are leading the fight against COVID-19 for people with asthma and allergies. But we need your help to continue to provide COVID-19...

Asthma and Allergy Caucus to FDA: Take Action to Prevent Albuterol Shortages

Congressmen Eliot L. Engel (D-NY) and Fred Upton (R-MI), Co-Chairs of the Asthma and Allergy Caucus, joined by Congressmen TJ Cox (D-CA) and Peter King (R-NY), Members of Caucus, led 57 Members of the House on a letter to the Food and Drug Administration (FDA) about shortages of albuterol inhalers, which are critical to effective asthma management.

Asthma Drug Shortages During COVID-19: A Letter From AAFA’s President and CEO

Because of the COVID-19 (new coronavirus) pandemic, we are facing a challenging and unprecedented time. COVID-19 is a respiratory infection, and the nearly 25 million Americans with asthma are at high risk for complications from the virus. As the leading patient organization for people with asthma and allergies, this has the Asthma and Allergy Foundation of America (AAFA) deeply concerned for your health and well-being.

Emotional Support Animals on Planes: AAFA Submits Comment to the DOT

In January, the U.S. Department of Transportation (DOT) proposed new rules regarding animals on planes . If passed, airlines would no longer be forced to recognize emotional support animals as service animals and may treat them as pets. The Asthma and Allergy Foundation of America (AAFA) has submitted our comment to the DOT on behalf of people with asthma and allergies. Read our comment below. We also encourage you to submit your own comment to the DOT about emotional support animals on...

Clean Air, Sharp Minds Act Aims to Improve Indoor Air Quality in Schools to Improve Student Health and Learning

On Feb. 27, 2020, Senator Cory Booker and Representative Katherine Clark introduced the Clean Air, Sharp Minds Act. The proposed act would give schools a three-year grant to help them improve indoor air quality (IAQ) . The grant would allow schools in high pollution areas or that pose a severe health and safety threat to install commercial air filters. This program would be managed by the Department of Education and the Environmental Protection Agency (EPA). These grants aim to: Improve the...

February Advocacy Update: Over-the-Counter Medicines, Restaurant Safety and Cleaner Cars

Welcome to your February advocacy update. I’m Jenna Riemenschneider, director of advocacy at the Asthma and Allergy Foundation of America (AAFA). I am pictured above with AAFA board member Renuka Babu Brown and Senator Ed Markey's (D-MA) policy advisor Adam Axler. Over-the-Counter Drug Access and Cleaner Cars Rollbacks AAFA and other members of the Healthy Choices Coalition met with Representative Judy Chu's office. We asked her to co-sponsor the Restoring Access to Medication Act of 2019...

Post
×
×
×
×